Cerapedics i-Factor manufacture method wins US patent

i- Factor biologic bone graft utilizes the company’s proprietary anorganic bone mineral (ABM) and synthetic small peptide (P-15) technologies used in orthopedic surgical, spine and trauma. procedures.

i-FACTOR biologic bone graft is currently being evaluated by the US FDA as part of an Investigational Device Exemption (IDE) clinical study in the cervical spine.

Sign up for our weekly news round-up!

Give your business an edge with our leading industry insights.

Sign up